RAPT Therapeutics Ownership 2024 | Who Owns RAPT Therapeutics Now?


OverviewForecastRevenueFinancialsChart

Institutional Ownership

8.93%

Insider Ownership

1.84%

Retail Ownership

89.23%

Institutional Holders

27.00

RAPT Therapeutics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FMR LLC13.55%0.00%5,235,52115,8660.30%15,968,340Jun 30, 2024
VANGUARD GROUP INC8.05%0.00%3,108,268615,41824.69%9,480,217Jun 30, 2024
COLUMN GROUP LLC6.94%11.47%2,680,621--8,175,894Jun 30, 2024
BLACKROCK INC.6.32%0.00%2,439,830-32,323-1.31%7,441,481Jun 30, 2024
KINGDON CAPITAL MANAGEMENT, L.L.C.4.47%0.56%1,725,000225,00015.00%5,261,250Jun 30, 2024
MORGAN STANLEY3.05%0.00%1,178,895-726,439-38.13%3,595,630Jun 30, 2024
MILLENNIUM MANAGEMENT LLC2.65%0.00%1,024,061781,906322.89%3,123,386Jun 30, 2024
DEUTSCHE BANK AG\2.41%0.00%932,541643,031222.11%2,844,250Jun 30, 2024
D. E. SHAW & CO., INC.2.35%0.00%907,413637,272235.90%2,767,610Jun 30, 2024
FEDERATED HERMES, INC.2.06%0.01%796,080520,368188.74%2,428,044,000Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.1.83%0.01%707,300706,900176725.00%2,157,265Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC1.77%0.00%684,7135,4970.81%2,088,661Jun 30, 2024
STATE STREET CORP1.74%0.00%671,78512,3831.88%2,048,944,000Jun 30, 2024
EUCLIDEAN CAPITAL LLC1.70%0.25%657,899--2,006,592Jun 30, 2024
TWO SIGMA INVESTMENTS, LP1.59%0.00%612,305186,70243.87%1,867,530Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC1.41%0.19%545,000-32,100-5.56%1,662,250Jun 30, 2024
ALPHABET INC.1.40%0.08%540,270--1,647,824Jun 30, 2024
REDMILE GROUP, LLC1.39%0.10%536,682-125,716-18.98%1,636,880Jun 30, 2024
ARDSLEY ADVISORY PARTNERS LP1.29%0.22%500,00097,50024.22%1,525,000Jun 30, 2024
CORMORANT ASSET MANAGEMENT, LP1.29%0.09%496,750--1,515,088Jun 30, 2024

RAPT Therapeutics's largest institutional shareholder is FMR LLC, holding 13.55% of the company's total share outstanding, currently valued at $15.97M. The top 10 institutional shareholders own together 51.85% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
COLUMN GROUP LLC6.94%11.47%2,680,621--8,175,894Jun 30, 2024
KINGDON CAPITAL MANAGEMENT, L.L.C.4.47%0.56%1,725,000225,00015.00%5,261,250Jun 30, 2024
GHOST TREE CAPITAL, LLC0.78%0.29%300,000--915,000Jun 30, 2024
SIO CAPITAL MANAGEMENT, LLC0.82%0.26%315,000--960,750Jun 30, 2024
EUCLIDEAN CAPITAL LLC1.70%0.25%657,899--2,006,592Jun 30, 2024
ALTIUM CAPITAL MANAGEMENT LP0.52%0.25%200,000200,000100.00%610,000Jun 30, 2024
ARDSLEY ADVISORY PARTNERS LP1.29%0.22%500,00097,50024.22%1,525,000Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC1.41%0.19%545,000-32,100-5.56%1,662,250Jun 30, 2024
OCTAGON CAPITAL ADVISORS LP0.76%0.14%292,000--890,600Jun 30, 2024
IKARIAN CAPITAL, LLC0.01%0.11%2,000-85,200-97.71%610,000Jun 30, 2024
REDMILE GROUP, LLC1.39%0.10%536,682-125,716-18.98%1,636,880Jun 30, 2024
CORMORANT ASSET MANAGEMENT, LP1.29%0.09%496,750--1,515,088Jun 30, 2024
ALPHABET INC.1.40%0.08%540,270--1,647,824Jun 30, 2024
IKARIAN CAPITAL, LLC0.40%0.08%154,625--471,606Jun 30, 2024
PDT PARTNERS, LLC0.25%0.03%97,80597,805100.00%298,305Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC0.19%0.03%75,00075,000100.00%228,750Jun 30, 2024
XTX TOPCO LTD0.09%0.01%35,48035,480100.00%108,214Jun 30, 2024
GSA CAPITAL PARTNERS LLP0.09%0.01%36,65436,654100.00%112,000Jun 30, 2024
HENNION & WALSH ASSET MANAGEMENT, INC.0.13%0.01%48,5253,8248.55%148,001Jun 30, 2024
TREXQUANT INVESTMENT LP0.37%0.01%144,362-13,280-8.42%440,304Jun 30, 2024

The largest RAPT Therapeutics shareholder by % of total assets is COLUMN GROUP LLC. The company owns 2.68M shares of RAPT Therapeutics (RAPT), representing 11.47% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MILLENNIUM MANAGEMENT LLC2.65%0.00%1,024,061781,906322.89%3,123,386Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.1.83%0.01%707,300706,900176725.00%2,157,265Jun 30, 2024
DEUTSCHE BANK AG\2.41%0.00%932,541643,031222.11%2,844,250Jun 30, 2024
D. E. SHAW & CO., INC.2.35%0.00%907,413637,272235.90%2,767,610Jun 30, 2024
VANGUARD GROUP INC8.05%0.00%3,108,268615,41824.69%9,480,217Jun 30, 2024
FEDERATED HERMES, INC.2.06%0.01%796,080520,368188.74%2,428,044,000Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC1.21%0.00%467,182456,2754183.32%1,424,000Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC0.76%0.01%295,241263,372826.42%900,485Jun 30, 2024
KINGDON CAPITAL MANAGEMENT, L.L.C.4.47%0.56%1,725,000225,00015.00%5,261,250Jun 30, 2024
ALTIUM CAPITAL MANAGEMENT LP0.52%0.25%200,000200,000100.00%610,000Jun 30, 2024
GOLDMAN SACHS GROUP INC0.97%0.00%373,788187,565100.72%1,140,054Jun 30, 2024
TWO SIGMA INVESTMENTS, LP1.59%0.00%612,305186,70243.87%1,867,530Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.39%0.00%150,000120,000400.00%457,500Jun 30, 2024
SQUAREPOINT OPS LLC0.28%0.00%107,994107,994100.00%329,382Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC0.53%0.00%203,900105,900108.06%621,895Jun 30, 2024
NORGES BANK0.26%-100,300100,300100.00%305,915Jun 30, 2024
PDT PARTNERS, LLC0.25%0.03%97,80597,805100.00%298,305Jun 30, 2024
ARDSLEY ADVISORY PARTNERS LP1.29%0.22%500,00097,50024.22%1,525,000Jun 30, 2024
AQR CAPITAL MANAGEMENT LLC0.23%0.00%88,37388,373100.00%269,538Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC0.19%0.03%75,00075,000100.00%228,750Jun 30, 2024

As of Jun 30 2024, RAPT Therapeutics's largest institutional buyer is MILLENNIUM MANAGEMENT LLC. The company purchased 781.91K stocks of RAPT, valued at $3.12M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PRICE T ROWE ASSOCIATES INC /MD/0.54%0.00%208,499-1,819,667-89.72%637,000Jun 30, 2024
PERCEPTIVE ADVISORS LLC----1,223,472-100.00%-Jun 30, 2024
MORGAN STANLEY3.05%0.00%1,178,895-726,439-38.13%3,595,630Jun 30, 2024
ALLY BRIDGE GROUP (NY) LLC----420,000-100.00%-Jun 30, 2024
CANDRIAM S.C.A.----313,262-100.00%-Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC----275,097-100.00%-Jun 30, 2024
IKARIAN CAPITAL, LLC----246,200-100.00%-Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP0.86%0.00%331,876-224,928-40.40%1,011,850Jun 30, 2024
WOODLINE PARTNERS LP0.43%0.00%165,981-155,632-48.39%506,242Jun 30, 2024
ARTIA GLOBAL PARTNERS LP----137,308-100.00%-Jun 30, 2024
REDMILE GROUP, LLC1.39%0.10%536,682-125,716-18.98%1,636,880Jun 30, 2024
IKARIAN CAPITAL, LLC0.01%0.11%2,000-85,200-97.71%610,000Jun 30, 2024
BARCLAYS PLC0.03%-10,534-82,083-88.63%31,000Jun 30, 2024
WELLINGTON MANAGEMENT GROUP LLP----80,642-100.00%-Jun 30, 2024
UBS OCONNOR LLC----73,088-100.00%-Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC----66,700-100.00%-Jun 30, 2024
VOYA INVESTMENT MANAGEMENT LLC----61,834-100.00%-Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC----60,000-100.00%-Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.----57,955-100.00%-Jun 30, 2024
JUMP FINANCIAL, LLC----51,500-100.00%-Jun 30, 2024

As of Jun 30 2024, RAPT Therapeutics's biggest institutional seller is PRICE T ROWE ASSOCIATES INC /MD/. The company sold -1.82M shares of RAPT, valued at $637.00K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ALTIUM CAPITAL MANAGEMENT LP0.52%0.25%200,000200,000100.00%610,000Jun 30, 2024
SQUAREPOINT OPS LLC0.28%0.00%107,994107,994100.00%329,382Jun 30, 2024
NORGES BANK0.26%-100,300100,300100.00%305,915Jun 30, 2024
PDT PARTNERS, LLC0.25%0.03%97,80597,805100.00%298,305Jun 30, 2024
AQR CAPITAL MANAGEMENT LLC0.23%0.00%88,37388,373100.00%269,538Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC0.19%0.03%75,00075,000100.00%228,750Jun 30, 2024
VERITION FUND MANAGEMENT LLC0.14%0.00%55,82555,825100.00%170,266Jun 30, 2024
THRIVENT FINANCIAL FOR LUTHERANS0.14%0.00%53,99353,993100.00%164,000Jun 30, 2024
PRUDENTIAL FINANCIAL INC0.14%0.00%53,64553,645100.00%163,617Jun 30, 2024
XTX TOPCO LTD0.09%0.01%35,48035,480100.00%108,214Jun 30, 2024
STIFEL FINANCIAL CORP0.05%0.00%17,42117,421100.00%53,135Jun 30, 2024
COREBRIDGE FINANCIAL, INC.0.04%0.00%16,13916,139100.00%49,224Jun 30, 2024
PALE FIRE CAPITAL SE0.04%0.01%16,07016,070100.00%49,014Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.0.04%0.00%14,64314,643100.00%44,661Jun 30, 2024
PRELUDE CAPITAL MANAGEMENT, LLC0.03%0.00%10,90010,900100.00%33,245Jun 30, 2024
CERITY PARTNERS LLC0.03%0.00%10,54610,546100.00%32,166Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.02%0.00%7,5007,500100.00%22,875Jun 30, 2024
RUSSELL INVESTMENTS GROUP, LTD.0.00%-1,3721,372100.00%4,184Jun 30, 2024
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC0.00%-914914100.00%2,787Jun 30, 2024
CAPTION MANAGEMENT, LLC0.00%-700700100.00%2,135Jun 30, 2024
PICTON MAHONEY ASSET MANAGEMENT0.00%-435435100.00%1,000Jun 30, 2024
SMARTLEAF ASSET MANAGEMENT LLC0.00%0.00%257257100.00%742Jun 30, 2024
EVERSOURCE WEALTH ADVISORS, LLC0.00%-127127100.00%399Jun 30, 2024
PNC FINANCIAL SERVICES GROUP, INC.0.00%-7878100.00%238Jun 30, 2024

RAPT Therapeutics's largest new institutional shareholder by number of shares is ALTIUM CAPITAL MANAGEMENT LP, purchased 200.00K shares, valued at $610.00K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PERCEPTIVE ADVISORS LLC----1,223,472-100.00%-Jun 30, 2024
ALLY BRIDGE GROUP (NY) LLC----420,000-100.00%-Jun 30, 2024
CANDRIAM S.C.A.----313,262-100.00%-Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC----275,097-100.00%-Jun 30, 2024
IKARIAN CAPITAL, LLC----246,200-100.00%-Jun 30, 2024
ARTIA GLOBAL PARTNERS LP----137,308-100.00%-Jun 30, 2024
WELLINGTON MANAGEMENT GROUP LLP----80,642-100.00%-Jun 30, 2024
UBS OCONNOR LLC----73,088-100.00%-Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC----66,700-100.00%-Jun 30, 2024
VOYA INVESTMENT MANAGEMENT LLC----61,834-100.00%-Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC----60,000-100.00%-Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.----57,955-100.00%-Jun 30, 2024
JUMP FINANCIAL, LLC----51,500-100.00%-Jun 30, 2024
POLAR ASSET MANAGEMENT PARTNERS INC.----46,500-100.00%-Jun 30, 2024
SWISS NATIONAL BANK----44,000-100.00%-Jun 30, 2024
OCCUDO QUANTITATIVE STRATEGIES LP----40,940-100.00%-Jun 30, 2024
HRT FINANCIAL LP----40,871-100.00%-Jun 30, 2024
DENALI ADVISORS LLC----32,600-100.00%-Jun 30, 2024
WOLVERINE TRADING, LLC----30,300-100.00%-Jun 30, 2024
FRANKLIN RESOURCES INC----25,877-100.00%-Jun 30, 2024
ALPS ADVISORS INC----24,259-100.00%-Jun 30, 2024
BANK OF AMERICA CORP /DE/----21,400-100.00%-Jun 30, 2024
STATE OF WISCONSIN INVESTMENT BOARD----20,208-100.00%-Jun 30, 2024
ENTRYPOINT CAPITAL, LLC----17,907-100.00%-Jun 30, 2024
TUDOR INVESTMENT CORP ET AL----16,749-100.00%-Jun 30, 2024
JANUS HENDERSON GROUP PLC----16,003-100.00%-Jun 30, 2024
METLIFE INVESTMENT MANAGEMENT, LLC----15,751-100.00%-Jun 30, 2024
AIGEN INVESTMENT MANAGEMENT, LP----14,940-100.00%-Jun 30, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.----14,743-100.00%-Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----14,556-100.00%-Jun 30, 2024
OXFORD ASSET MANAGEMENT LLP----13,594-100.00%-Jun 30, 2024
JEFFERIES FINANCIAL GROUP INC.----13,192-100.00%-Jun 30, 2024
QUANTBOT TECHNOLOGIES LP----11,300-100.00%-Jun 30, 2024
LIGHTHOUSE INVESTMENT PARTNERS, LLC----11,160-100.00%-Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC----7,500-100.00%-Jun 30, 2024
TORNO CAPITAL, LLC----4,500-100.00%-Jun 30, 2024
VIRTUS ETF ADVISERS LLC----4,479-100.00%-Jun 30, 2024
METROPOLITAN LIFE INSURANCE CO/NY----1,581-100.00%-Jun 30, 2024
GREAT WEST LIFE ASSURANCE CO /CAN/----1,159-100.00%-Jun 30, 2024
BELVEDERE TRADING LLC----886-100.00%-Jun 30, 2024
COMERICA BANK----222-100.00%-Jun 30, 2024
DAIWA SECURITIES GROUP INC.----101-100.00%-Jun 30, 2024
GAMMA INVESTING LLC----27-100.00%-Jun 30, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC----7-100.00%-Jun 30, 2024
FARTHER FINANCE ADVISORS, LLC----2-100.00%-Jun 30, 2024

RAPT Therapeutics's largest sold out institutional shareholder by shares sold is PERCEPTIVE ADVISORS LLC, sold -1.22M shares, valued at -, as of undefined.

RAPT Therapeutics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Alger ETF Trust3.64%25,859--Dec 31, 2023
HARTFORD HLS SERIES FUND II INC0.67%164,002--Dec 31, 2023
HSBC FUNDS0.29%9,3703,80068.22%Jan 31, 2024
T. Rowe Price New Horizons Fund, Inc.0.28%1,377,775-636,914-31.61%Mar 31, 2024
T. Rowe Price Small-Cap Stock Fund, Inc.0.13%466,322--Mar 31, 2024
Voya VARIABLE PRODUCTS TRUST0.12%42,045--Mar 31, 2024
ALGER FUNDS0.12%112,07568,434156.81%Jan 31, 2024
ALGER INSTITUTIONAL FUNDS0.10%26,1547,90743.33%Jan 31, 2024
FIDELITY MT VERNON STREET TRUST0.08%2,373,336675,67639.80%Feb 29, 2024
ALGER PORTFOLIOS0.08%28,9939,96652.38%Dec 31, 2023
BlackRock Health Sciences Trust II0.07%177,974--Mar 31, 2024
ALGER FUNDS II0.05%10,497-88,781-89.43%Jan 31, 2024
VANGUARD VALLEY FORGE FUNDS0.04%21,985--Mar 31, 2024
BlackRock Health Sciences Trust0.03%8,628--Mar 31, 2024
T. Rowe Price Equity Funds, Inc.0.02%218,507--Mar 31, 2024
T. Rowe Price Health Sciences Fund, Inc.0.02%64,030-438,861-87.27%Mar 31, 2024
Voya EQUITY TRUST0.02%25,161--Feb 29, 2024
VANGUARD HORIZON FUNDS0.02%363,450347,7442214.08%Mar 31, 2024
Humankind Benefit Corp0.02%3389136.84%Dec 31, 2023
FIDELITY SELECT PORTFOLIOS0.01%802,700--Feb 29, 2024
BNY Mellon Strategic Funds, Inc.0.01%24,403--Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC0.01%52,767-2,469-4.47%Mar 31, 2024
UBS FUNDS0.01%38,054-502-1.30%Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%4,548--Mar 31, 2024
FIDELITY COMMONWEALTH TRUST0.01%21,9993411.57%Feb 29, 2024
T. Rowe Price Quantitative Management Funds, Inc.0.01%17,073--Mar 31, 2024
VANGUARD INDEX FUNDS0.00%1,630,120-510,564-23.85%Mar 31, 2024
VANGUARD EXPLORER FUND0.00%44,125-27,826-38.67%Jan 31, 2024
Nushares ETF Trust0.00%26,126-821-3.05%Jan 31, 2024
ETFis Series Trust I0.00%4,243-448-9.55%Jan 31, 2024
VANGUARD QUANTITATIVE FUNDS0.00%14,00014,000-Mar 31, 2024
NEUBERGER BERMAN EQUITY FUNDS0.00%27,960--Feb 29, 2024
TIAA SEPARATE ACCOUNT VA 10.00%524--Mar 31, 2024
T. Rowe Price Equity Series, Inc.0.00%3,442-20,906-85.86%Mar 31, 2024
SCHWAB CAPITAL TRUST0.00%84,0594,7736.02%Jan 31, 2024
ALPS ETF Trust0.00%24,4591880.77%Feb 29, 2024
T. Rowe Price Spectrum Funds II, Inc.0.00%20,735--Feb 29, 2024
FIDELITY CONCORD STREET TRUST0.00%285,127-726-0.25%Feb 29, 2024
Fidelity Commonwealth Trust II0.00%8,7204,733118.71%Aug 31, 2023
AMG FUNDS0.00%37,025--Mar 28, 2024
VICTORY PORTFOLIOS0.00%39,590--Mar 31, 2024
HARTFORD SERIES FUND INC0.00%49,788--Mar 31, 2024
Calvert Variable Products, Inc.0.00%2,913--Mar 31, 2024
NORTHWESTERN MUTUAL SERIES FUND INC0.00%93,915--Mar 31, 2024
MML SERIES INVESTMENT FUND0.00%7,796--Dec 31, 2023
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%23,728-1,664-6.55%Mar 31, 2024
HARTFORD MUTUAL FUNDS II INC0.00%100,106--Jan 31, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.00%48,465-38,132-44.03%Jan 31, 2024
Direxion Shares ETF Trust0.00%87,90010,81514.03%Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%6,628801.22%Mar 31, 2024
Forethought Variable Insurance Trust0.00%2,277--Mar 28, 2024
BlackRock ETF Trust0.00%473--Jan 31, 2024
FIDELITY COVINGTON TRUST0.00%8,720--Mar 31, 2024
North Square Investments Trust0.00%4,030--Jan 31, 2024
VANGUARD VARIABLE INSURANCE FUNDS0.00%21,3466,14340.41%Mar 31, 2024
PUTNAM ASSET ALLOCATION FUNDS0.00%13,141-206-1.54%Mar 31, 2024
Principal Exchange-Traded Funds0.00%4,826-560-10.40%Mar 31, 2024
ETF Series Solutions0.00%8,4591,35519.07%Feb 29, 2024
Global X Funds0.00%16,631--Jan 31, 2024
Dimensional ETF Trust0.00%139,852-16,422-10.51%Jan 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%10,084-1,978-16.40%Mar 31, 2024
VANGUARD WORLD FUND0.00%76,4363840.50%Feb 29, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%1,475--Mar 31, 2024
Series Portfolios Trust0.00%1,8054,038-180.83%Jan 31, 2024
SCHWAB STRATEGIC TRUST0.00%154,59910,2067.07%Feb 29, 2024
T. Rowe Price Exchange-Traded Funds, Inc.0.00%1,560--Feb 29, 2024
THRIVENT SERIES FUND INC0.00%24,409--Mar 28, 2024
MFS VARIABLE INSURANCE TRUST III0.00%3,455--Mar 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%206,723-150,882-42.19%Jan 31, 2024
TIAA-CREF LIFE FUNDS0.00%468--Mar 31, 2024
SunAmerica Specialty Series0.00%90--Apr 30, 2021
NORTHERN FUNDS0.00%23,608-636-2.62%Mar 28, 2024
ADVISORS' INNER CIRCLE FUND0.00%3,783--Jan 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%10,000--Mar 31, 2024
Tidal Trust II0.00%3,144--Jan 31, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%493--Mar 31, 2024
SA FUNDS INVESTMENT TRUST0.00%1,843--Mar 31, 2024
THRIVENT MUTUAL FUNDS0.00%9,246--Mar 28, 2024
T. Rowe Price Index Trust, Inc.0.00%1,901-17,742-90.32%Mar 31, 2024
FLEXSHARES TRUST0.00%6,3086,308-Jan 31, 2024
iSHARES TRUST0.00%1,323,481-58,903-4.26%Mar 31, 2024
EQ ADVISORS TRUST0.00%84,926-9,390-9.96%Mar 31, 2024
VANGUARD SCOTTSDALE FUNDS0.00%134,47316,41413.90%Feb 29, 2024
Federated Hermes Global Allocation Fund0.00%629--Feb 29, 2024
RYDEX SERIES FUNDS0.00%269--Dec 31, 2023
Invesco Exchange-Traded Self-Indexed Fund Trust0.00%11,083--Feb 29, 2024
Blackstone Alternative Investment Funds0.00%5,9002,60078.79%Mar 31, 2024
RUSSELL INVESTMENT CO0.00%13,628--Jan 31, 2024
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%2,162--Dec 31, 2023
VALIC Co I0.00%11,335-46-0.40%Feb 29, 2024
PENN SERIES FUNDS INC0.00%1,000--Mar 28, 2024
RYDEX DYNAMIC FUNDS0.00%134--Dec 31, 2023
NATIONWIDE VARIABLE INSURANCE TRUST0.00%4,409-321-6.79%Mar 31, 2024
PROSHARES TRUST0.00%6,89788814.78%Feb 29, 2024
NATIONWIDE MUTUAL FUNDS0.00%3,402-310-8.35%Jan 31, 2024
SEASONS SERIES TRUST0.00%596--Mar 31, 2024
TIAA-CREF FUNDS0.00%69,182--Jan 31, 2024
VANGUARD WELLINGTON FUND0.00%8,784--Feb 29, 2024
SPDR SERIES TRUST0.00%817,012--Mar 31, 2024
Guggenheim Active Allocation Fund0.00%127--Feb 29, 2024

RAPT Therapeutics's largest mutual fund holder by % of total assets is "Alger ETF Trust", owning 25.86K shares, compromising 3.64% of its total assets.

RAPT Therapeutics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 2427-80.71%
31 Mar, 2414019.66%
31 Dec, 2311715.84%
30 Sep, 231011.00%
30 Jun, 23100-9.09%
31 Mar, 2311012.24%
31 Dec, 2298-2.00%
30 Sep, 2210013.64%
30 Jun, 22883.53%
31 Mar, 2285-21.30%
31 Dec, 21108-9.24%
30 Sep, 21119-9.16%
30 Jun, 2113147.19%
31 Mar, 2189-1.11%
31 Dec, 209030.43%
30 Sep, 206930.19%
30 Jun, 205343.24%
31 Mar, 203737.04%
31 Dec, 1927-

As of 30 Jun 24, 27 institutions are holding RAPT Therapeutics's shares, representing a decrease of -80.71% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 243,448,478-89.18%
31 Mar, 2431,861,728-8.92%
31 Dec, 2334,982,1260.63%
30 Sep, 2334,763,4272.09%
30 Jun, 2334,050,2662.26%
31 Mar, 2333,297,1143.59%
31 Dec, 2232,142,8287.26%
30 Sep, 2229,968,2970.77%
30 Jun, 2229,739,4516.12%
31 Mar, 2228,023,1710.61%
31 Dec, 2127,851,9345.49%
30 Sep, 2126,402,711-0.93%
30 Jun, 2126,650,77926.30%
31 Mar, 2121,101,6003.21%
31 Dec, 2020,445,87921.49%
30 Sep, 2016,829,46711.95%
30 Jun, 2015,033,46428.68%
31 Mar, 2011,682,59127.83%
31 Dec, 199,139,447-

RAPT Therapeutics (RAPT) has 3.45M shares outstanding as of 30 Jun 24, down -89.18% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 248.93%0.13%
31 Mar, 2483.01%1.00%
31 Dec, 2391.20%1.11%
30 Sep, 2390.70%1.15%
30 Jun, 2388.95%1.18%
31 Mar, 2386.98%1.07%
31 Dec, 2290.06%1.14%
30 Sep, 2288.97%0.98%
30 Jun, 2295.50%1.06%
31 Mar, 2294.76%1.07%
31 Dec, 2194.29%1.18%
30 Sep, 2189.53%0.83%
30 Jun, 21104.15%1.44%
31 Mar, 2184.93%1.18%
31 Dec, 2084.72%1.79%
30 Sep, 2068.83%1.80%
30 Jun, 2061.77%2.45%
31 Mar, 2050.21%1.40%
31 Dec, 1959.91%-

As of 30 Jun 24, RAPT Therapeutics is held by 8.93% institutional shareholders, representing a 0.13% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2415-80.00%
31 Mar, 247519.05%
31 Dec, 236350.00%
30 Sep, 2342-12.50%
30 Jun, 2348-18.64%
31 Mar, 2359-6.35%
31 Dec, 22638.62%
30 Sep, 225831.82%
30 Jun, 224410.00%
31 Mar, 2240-9.09%
31 Dec, 2144-36.23%
30 Sep, 2169-14.81%
30 Jun, 2181170.00%
31 Mar, 2130-49.15%
31 Dec, 205943.90%
30 Sep, 2041-6.82%
30 Jun, 204457.14%
31 Mar, 20283.70%
31 Dec, 1927-

15 institutional shareholders have increased their position in RAPT stock as of 30 Jun 24 compared to 75 in the previous quarter (a -80.00% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 248-73.33%
31 Mar, 2430-14.29%
31 Dec, 2335-7.89%
30 Sep, 233815.15%
30 Jun, 233310.00%
31 Mar, 2330130.77%
31 Dec, 2213-38.10%
30 Sep, 2221-19.23%
30 Jun, 2226-7.14%
31 Mar, 2228-24.32%
31 Dec, 213723.33%
30 Sep, 213030.43%
30 Jun, 2123-14.81%
31 Mar, 212768.75%
31 Dec, 2016-
30 Sep, 2016433.33%
30 Jun, 203-40.00%
31 Mar, 205-
31 Dec, 19--

8 institutional shareholders have reduced their position in RAPT stock as of 30 Jun 24 compared to 30 in the previous quarter (a -73.33% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 2427-80.71%3,448,478-89.18%8.93%0.13%15-80.00%8-73.33%
31 Mar, 2414019.66%31,861,728-8.92%83.01%1.00%7519.05%30-14.29%
31 Dec, 2311715.84%34,982,1260.63%91.20%1.11%6350.00%35-7.89%
30 Sep, 231011.00%34,763,4272.09%90.70%1.15%42-12.50%3815.15%
30 Jun, 23100-9.09%34,050,2662.26%88.95%1.18%48-18.64%3310.00%
31 Mar, 2311012.24%33,297,1143.59%86.98%1.07%59-6.35%30130.77%
31 Dec, 2298-2.00%32,142,8287.26%90.06%1.14%638.62%13-38.10%
30 Sep, 2210013.64%29,968,2970.77%88.97%0.98%5831.82%21-19.23%
30 Jun, 22883.53%29,739,4516.12%95.50%1.06%4410.00%26-7.14%
31 Mar, 2285-21.30%28,023,1710.61%94.76%1.07%40-9.09%28-24.32%
31 Dec, 21108-9.24%27,851,9345.49%94.29%1.18%44-36.23%3723.33%
30 Sep, 21119-9.16%26,402,711-0.93%89.53%0.83%69-14.81%3030.43%
30 Jun, 2113147.19%26,650,77926.30%104.15%1.44%81170.00%23-14.81%
31 Mar, 2189-1.11%21,101,6003.21%84.93%1.18%30-49.15%2768.75%
31 Dec, 209030.43%20,445,87921.49%84.72%1.79%5943.90%16-
30 Sep, 206930.19%16,829,46711.95%68.83%1.80%41-6.82%16433.33%
30 Jun, 205343.24%15,033,46428.68%61.77%2.45%4457.14%3-40.00%
31 Mar, 203737.04%11,682,59127.83%50.21%1.40%283.70%5-
31 Dec, 1927-9,139,447-59.91%-27---

RAPT Therapeutics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jan 08, 2024Brockstedt Dirk G.officer CHIEF SCIENTIFIC OFFICERS-SaleSell898$22.78$20.46K27,820
Dec 22, 2023HO WILLIAMofficer Chief Medical OfficerS-SaleSell2,500$21.68$54.20K15,020
Nov 29, 2023HO WILLIAMofficer Chief Medical OfficerS-SaleSell1,500$13.72$20.58K17,520
Oct 04, 2023HO WILLIAMofficer Chief Medical OfficerS-SaleSell2,500$15.77$39.42K18,789
Aug 22, 2023HO WILLIAMofficer Chief Medical OfficerS-SaleSell2,500$18.92$47.30K21,289

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jan 08, 2024Brockstedt Dirk G.officer CHIEF SCIENTIFIC OFFICERS-SaleSell898$22.78$20.46K27,820
Dec 22, 2023HO WILLIAMofficer Chief Medical OfficerS-SaleSell2,500$21.68$54.20K15,020
Nov 29, 2023HO WILLIAMofficer Chief Medical OfficerS-SaleSell1,500$13.72$20.58K17,520
Oct 04, 2023HO WILLIAMofficer Chief Medical OfficerS-SaleSell2,500$15.77$39.42K18,789
Aug 22, 2023HO WILLIAMofficer Chief Medical OfficerS-SaleSell2,500$18.92$47.30K21,289

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 23, 2024Robbins Wendyedirector-A-AwardBuy36,490$4.63$168.95K36,490
May 23, 2024RIEFLIN WILLIAM JLdirector-A-AwardBuy36,490$4.63$168.95K36,490
May 23, 2024Lyons-Williams Loridirector-A-AwardBuy36,490$4.63$168.95K36,490
May 23, 2024Kozick Lindadirector-A-AwardBuy36,490$4.63$168.95K36,490
May 23, 2024GRAY MARY ANNdirector-A-AwardBuy36,490$4.63$168.95K36,490
May 23, 2024Giordano Michael Fdirector-A-AwardBuy36,490$4.63$168.95K36,490
Apr 01, 2024Robbins Wendyedirector-A-AwardBuy6,925$8.98$62.19K6,925
Apr 01, 2024GRAY MARY ANNdirector-A-AwardBuy8,574$8.98$76.99K8,574
Apr 01, 2024RIEFLIN WILLIAM JLdirector-A-AwardBuy11,871$8.98$106.60K11,871
Feb 01, 2024HO WILLIAMofficer CHIEF MEDICAL OFFICERA-AwardBuy75,000$24.75$1.86M75,000
Feb 01, 2024Young Rodney KBofficer CHIEF FINANCIAL OFFICERA-AwardBuy90,000$24.75$2.23M90,000
Feb 01, 2024Brockstedt Dirk G.officer CHIEF SCIENTIFIC OFFICERA-AwardBuy75,000$24.75$1.86M75,000
Feb 01, 2024Wong Brian Russelldirector, officer PRESIDENT AND CEOA-AwardBuy275,000$24.75$6.81M275,000
Jan 08, 2024Brockstedt Dirk G.officer CHIEF SCIENTIFIC OFFICERS-SaleSell898$22.78$20.46K27,820
Jan 02, 2024Brockstedt Dirk G.officer Chief Scientific OfficerM-ExemptBuy8,000$6.18$49.44K27,070
Jan 02, 2024Brockstedt Dirk G.officer Chief Scientific OfficerM-ExemptBuy8,000$6.18$49.44K7,690
Dec 22, 2023HO WILLIAMofficer Chief Medical OfficerS-SaleSell2,500$21.68$54.20K15,020
Nov 29, 2023HO WILLIAMofficer Chief Medical OfficerS-SaleSell1,500$13.72$20.58K17,520
Oct 04, 2023HO WILLIAMofficer Chief Medical OfficerS-SaleSell2,500$15.77$39.42K18,789
Aug 22, 2023HO WILLIAMofficer Chief Medical OfficerS-SaleSell2,500$18.92$47.30K21,289

The last insider sell of RAPT Therapeutics's stock was made by Brockstedt Dirk G. on Jan 08 2024, selling 898 shares at $22.78 per share (valued at $20.46K).

RAPT Therapeutics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20246--
Q1 202471700.00%
Q4 20232366.67%
Q3 20231250.00%
Q2 202383266.67%
Q1 2023147200.00%
Q4 20222633.33%
Q3 202261154.55%
Q2 2022359388.89%
Q1 20221916118.75%
Q4 202161060.00%
Q3 2021298334.94%
Q2 20212614185.71%
Q1 20211716106.25%
Q4 202082433.33%
Q3 2020101855.56%
Q2 20202215146.67%
Q1 202016--
Q4 20195747121.28%

6 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by RAPT Therapeutics's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024---
Q1 2024-1-
Q4 2023-3-
Q3 2023-1-
Q2 2023-1-
Q1 202344100.00%
Q4 2022-4-
Q3 2022-2-
Q2 2022213700.00%
Q1 2022-6-
Q4 20212540.00%
Q3 2021106016.67%
Q2 20211410140.00%
Q1 2021-11-
Q4 202031323.08%
Q3 202081266.67%
Q2 20206966.67%
Q1 2020---
Q4 20196--

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of RAPT Therapeutics's stocks.

RAPT Therapeutics Peer Ownership


TickerCompany
PLRXPliant Therapeutics, Inc.
PMVPPMV Pharmaceuticals, Inc.
ARVNArvinas, Inc.
IKNAIkena Oncology, Inc.
MLYSMineralys Therapeutics, Inc.
STOKStoke Therapeutics, Inc.
BDTXBlack Diamond Therapeutics, Inc.
RLAYRelay Therapeutics, Inc.
TYRATyra Biosciences, Inc.
CNTBConnect Biopharma Holdings Limited
ANTXAN2 Therapeutics, Inc.
HCWBHCW Biologics Inc.
GLUEMonte Rosa Therapeutics, Inc.
DSGNDesign Therapeutics, Inc.
PHVSPharvaris N.V.
HOWLWerewolf Therapeutics, Inc.
PEPGPepGen Inc.
ANEBAnebulo Pharmaceuticals, Inc.
XLOXilio Therapeutics, Inc.
MOLNMolecular Partners AG
ELYMEliem Therapeutics, Inc.

RAPT Ownership FAQ


RAPT Therapeutics is owned by institutional shareholders (8.93%), insiders (1.84%), and public (89.23%). The largest institutional shareholder of RAPT Therapeutics is FMR LLC (13.55% of total shares) and the top mutual fund owner is Alger ETF Trust (3.64% of total shares).

RAPT Therapeutics's major institutional shareholders are FMR LLC, VANGUARD GROUP INC, COLUMN GROUP LLC, BLACKROCK INC., and KINGDON CAPITAL MANAGEMENT, L.L.C.. The top five shareholders own together 39.32% of the company's share outstanding.

As of Jun 2024, there are 27 institutional shareholders of RAPT Therapeutics.

FMR LLC owns 5.24M shares of RAPT Therapeutics, representing 13.55% of the company's total shares outstanding, valued at $15.97M (as of Jun 2024).

As of Jun 2024, VANGUARD GROUP INC holds 3.11M shares of RAPT Therapeutics (RAPT), compromising 8.05% of the company, valued at $9.48M.

COLUMN GROUP LLC is the third largest holder of RAPT Therapeutics. The company owns 2.68M of the company's shares outstanding (worth $8.18M).